By Dr. Pooja Varshney | MBBS, MD Dermatology | DermaTales Skin Clinic, Gurugram and Delhi
A 22 year old came in last month with two photos on his phone. One from a college function eight months ago, one from that morning. He held them side by side and asked me a question I hear more often every year: "Is this normal at my age, or is something wrong with me?"
Neither answer is quite right, and that is exactly the problem. Male pattern baldness has always started young for a meaningful share of men. What has changed is how many of them are noticing it early, worrying about it early, and still waiting far too long to actually do anything about it.
Around 25 percent of men with male pattern baldness begin losing hair before the age of 21. By 35, roughly two out of every three men will have some visible thinning. By 50, that figure rises to about 85 percent. Studies looking specifically at younger men have found that as many as 16 percent of men between 18 and 29 already show signs of it, compared to over half of men in their forties.
Whether this counts as baldness genuinely starting earlier, or simply being noticed and searched for earlier because of how much attention hair has online now, is not fully settled in the research. What is settled is this: the age at which a man decides to do something about his hair loss has not kept pace with the age at which it actually begins.
Male pattern baldness, medically called androgenetic alopecia, is not the same as general thinning or stress-related shedding. It follows a specific, predictable path driven by genetics and a hormone called dihydrotestosterone (DHT), which gradually shrinks hair follicles at the hairline and crown over time.
This is why it typically shows up first as a receding hairline, thinning at the temples, or a widening crown, rather than even thinning across the whole scalp, which is more typical of stress-related hair loss (telogen effluvium) or the female pattern.
This distinction matters clinically. A man treating pattern baldness with the wrong approach—assuming it is diet, stress, or a product issue—often loses months or years of the window where treatment is most effective.
Genetics from either side of the family plays the largest role in who develops this condition and when, which is why family history is one of the first things I ask about in a consultation. But there is a second layer worth knowing:
Several studies have found that men with early-onset androgenetic alopecia (meaning it began before age 35) have a meaningfully higher likelihood of metabolic syndrome—a cluster of conditions including insulin resistance, high blood pressure, and abnormal cholesterol that raises long-term cardiovascular risk.
Clinical Takeaway: This does not mean early hair loss causes these conditions, or that every young man with a receding hairline has an underlying metabolic problem. It does mean early-onset pattern baldness is worth treating as a reasonable prompt to get basic bloodwork done alongside any hair treatment plan, not purely as a cosmetic concern to be handled separately from the rest of your health.
Two treatments currently have real, consistent clinical evidence behind them for slowing down and addressing male pattern baldness:
Works by blocking the 5-alpha reductase enzyme that converts testosterone into DHT, addressing the root hormonal driver directly. Taken as a daily tablet or formulated as a targeted topical solution under dermatologist supervision.
Works differently by improving blood flow and micro-circulation to the hair follicle and extending its anagen (growth) phase. Applied topically to the scalp on affected areas.
Used together, they tend to outperform either one alone, though the right combination and dosing depends on how advanced the hair loss already is and how your body responds. This is exactly why a proper diagnosis before starting either matters more than picking whichever one a friend recommended.
The single biggest factor in how well any of this works is not the treatment—it is timing. Follicles that have been dormant for years respond far less predictably than follicles caught early in the miniaturization process, which is the entire reason early diagnosis changes the outcome as much as it does.
If your hairline has started moving, the question worth asking is not whether this is normal for your age. It usually is. The question worth asking is how much of this window you still have left to act on, because that window is the one part of this condition that does not wait.
If you are noticing early changes, our comparison of PRP and GFC hair treatment options covers what advanced clinical therapies are available if medication alone is not the right fit for you. A proper diagnosis is the only way to know where you actually stand.
Note: Treatment suitability and results vary from patient to patient. This article is for informational purposes and does not substitute a clinical consultation.
Dr. Pooja Varshney (MBBS, MD Dermatology) is a Consultant Dermatologist and Aesthetic Physician practising since 2015. She specialises in medical, cosmetic and hair dermatology and leads DermaTales Skin Clinic across Gurugram and Delhi.